Christine Fandozzi

Molecular modeling based approach to potent P2-P4 macrocyclic inhibitors of hepatitis C NS3/4A protease.

M. Katharine Holloway, M. Rudd, M. Holloway, 2008, Journal of the American Chemical Society.

MK-7009, a Potent and Selective Inhibitor of Hepatitis C Virus NS3/4A Protease

D. Hazuda, M. Rudd, D. Graham, 2009, Antimicrobial Agents and Chemotherapy.